The new bioaffinity membranes comprise mammalian blood and tissue cell
s immobilized in the polymer matrix. The method of immobilization does
not assume the retention of physiological and enzymatic activity of i
mmobilized cells, but it ensures the safety of cellular membrane recep
tors that are used as specific ligands. Macroporous polymer carriers b
ased on polyacrylonitrile maintain the accessibility of the cellular r
eceptors for all blood plasma components including immunoglobulins and
viral particles. The sorption capacity of membranes with respect to m
odel substances in a batchwise technique is evaluated. Although the re
sults are of a preliminary nature, the membranes may be used in crossf
low modules for selective blood plasma correction of endogenous substa
nces.